Ovarian cancer is often diagnosed at an advanced stage because symptoms in the early phases are vague or easily overlooked. Over the past decade, treatment options have evolved significantly – one of the biggest advancements being targeted therapy. Instead of attacking healthy and cancer cells together, these therapies work by focusing on specific molecules or pathways that help cancer cells grow.
In this blog, we explore what targeted therapy is, how it helps, who can benefit, and what to expect.
Understanding Targeted Therapy: A Simple Explanation
Targeted therapy uses medicines that “target” certain genetic changes or proteins found in ovarian cancer cells. Unlike chemotherapy, which affects the entire body, these treatments zero in on cancer-specific mechanisms.
How targeted therapy works
- Blocks signals that help cancer grow
- Prevents the formation of new blood vessels
- Repairs or stops the DNA damage that cancer relies on
- Weakens cancer cells so other treatments work better
- Reduces the chances of recurrence in some patients
Types of Targeted Therapy Used in Ovarian Cancer
Common Targeted Therapies for Ovarian Cancer
| Type of Therapy | How It Works | Who Benefits Most |
|---|---|---|
| PARP inhibitors (Olaparib, Niraparib, Rucaparib) | Blocks DNA repair in cancer cells, causing them to die | Patients with BRCA mutations or HRD-positive cancer |
| Anti-angiogenic therapy (Bevacizumab) | Stops formation of new blood vessels that feed tumors | Advanced or recurrent ovarian cancer patients |
| Targeted monoclonal antibodies | Attaches to specific proteins on cancer cells | Selected cases based on tumor testing |
| Antibody-drug conjugates (Emerging) | Combines a targeted antibody with a cancer-killing drug | Under research; used in certain resistant cancers |
When Is Targeted Therapy Recommended?
Doctors may suggest targeted therapy:
- After initial surgery and chemotherapy
- During recurrence
- If genetic testing shows BRCA or HRD positivity
- In advanced-stage disease
- As a maintenance therapy to prevent relapse
- When cancer does not respond well to standard treatment
Key takeaway: Targeted therapy is not for every patient. Treatment is based on genetic testing and individual disease behavior.
Benefits of Targeted Therapy in Ovarian Cancer
Targeted therapy has transformed the treatment landscape by adding precision and personalization.
Key benefits include:
- Better survival outcomes in many eligible patients
- Reduced relapse rates
- Fewer side effects compared to traditional chemotherapy
- Improved quality of life
- More options for recurrent disease
- Personalized treatment based on tumor biology
Detailed Look: How PARP Inhibitors Help
PARP inhibitors are among the most important targeted therapies in ovarian cancer.
They help by:
- Blocking repair of damaged DNA
- Causing cancer cells to self-destruct
- Enhancing the effect of chemotherapy
- Delaying disease progression
- Increasing treatment-free intervals
Who benefits the most?
- Patients with BRCA1/BRCA2 mutations
- Those with HRD-positive tumors
- Some patients without BRCA mutation (depending on tumor behavior)
Anti-Angiogenic Therapy: Cutting the Blood Supply
Bevacizumab is the most commonly used anti-angiogenic drug.
How it helps:
- Shrinks tumors by starving them
- Slows progression of disease
- Adds benefit when combined with chemotherapy
- Helps in both first-line and recurrent settings
Patients with aggressive or advanced disease often gain significant benefit.
Side Effects: What Patients Should Know
Targeted therapies are generally well tolerated, but they still come with manageable side effects.
Common Side Effects of PARP Inhibitors
- Fatigue
- Mild nausea
- Low blood counts
- Loss of appetite
- Headache
Common Side Effects of Bevacizumab
- High blood pressure
- Protein in urine
- Mild bleeding
- Delayed wound healing
Most side effects improve with dose adjustments and supportive care.
Role of Genetic Testing in Choosing Targeted Therapy
Targeted therapy decisions rely heavily on genetic and molecular testing.
Types of Tests Used
- BRCA testing (germline and somatic)
- HRD testing
- Next-generation sequencing (NGS)
- Tumor marker analysis
Why testing is essential:
It tells your doctor which medicine will work best and avoids unnecessary treatment.
How Targeted Therapy Fits With Other Treatments
Targeted therapy is not used alone in all cases. It may be combined with:
- Surgery
- Chemotherapy
- Immunotherapy
- Hormonal therapy (in rare subtypes)
- Maintenance treatment post-chemotherapy
Treatment Flow (Simplified)
- Diagnosis + Scans + Bloodwork
- Surgery to remove tumor (if possible)
- Chemotherapy
- Genetic testing
- Targeted therapy (maintenance or recurrence)
This strategy helps many patients live longer, healthier lives.
Lifestyle Tips During Targeted Therapy
Simple lifestyle changes can improve overall well-being:
Diet Tips
- Include antioxidant-rich fruits
- Eat a protein-rich diet
- Stay hydrated
- Reduce processed foods
Daily Habits
- Light walks
- Yoga or stretching
- Stress-relief activities
- Adequate sleep
Emotional Support
- Join a support group
- Talk openly with caregivers
- Seek professional counseling if needed
Short FAQ Section
- Is targeted therapy better than chemotherapy?
Not always, Both treatments have different roles. Targeted therapy works best when specific genetic changes are present. - Can everyone with ovarian cancer receive targeted therapy?
No, Eligibility depends on genetic testing results and clinical evaluation. - Are targeted therapies safe?
Yes, they are generally well tolerated. Side effects are manageable. - How long does targeted therapy continue?
Many patients take it as a maintenance treatment for months or years depending on response. - Can targeted therapy cure ovarian cancer?
It does not cure the disease, but it significantly improves survival and quality of life.
Conclusion
Targeted therapy has brought new hope for women with ovarian cancer by providing treatment options that are more personalized and precise. When used in the right patients especially those with BRCA or HRD-positive tumors, it can delay disease progression, reduce recurrence, and improve overall well-being.
If you or your loved one has recently been diagnosed, talk to your oncologist about the availability of genetic testing and whether targeted therapy may be a suitable option. Modern cancer care is no longer one-size-fits-all. The right treatment, chosen wisely, can truly make a meaningful difference.